UNSPSC 51281712: Amoxicillin sodium

This classification denotes a penicillin antibiotic with the molecular formula C16H18N3O5S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 544Y3D6MYH, chemically known as sodium (2s-(2alpha,5alpha,6beta(s*)))-6-((amino(4-hydroxyphenyl)acetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate but more generally known as amoxicillin sodium, which bears US NIH Compound Identifier 91616. amoxicillin most often comes in base, anhydrous, hydrate, natrium, sodium, and trihydrate forms and is often combined with clavulinic acid.

UNSPSC 51281712 Amoxicillin sodium, a Commodity code, shows minimal recent activity aligned with its narrow pharmaceutical scope. The code appears in state and local procurement systems but does not match the work actually being solicited under it; recent opportunities tagged to this code involve naloxone procurement, medical and first aid supplies, and generic pharmaceutical contracting frameworks rather than amoxicillin specifically. A review of recent state and local contract opportunities reveals no direct solicitations for amoxicillin sodium itself, suggesting the code either reflects historical purchasing patterns that have shifted or mislabeling in source records.

The most recent activity shows issuing bodies in Florida, Texas, Minnesota, and Oregon pursuing pharmacy and medical-supply procurement through broader channels. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) for naloxone and drug deactivation systems with annual quantities of 1,900 units and 800 systems. The Texas Health and Human Services Commission posted an RFI (HHS0017013, response due April 3, 2026) on direct-to-manufacturer prescription programs. The City of Tampa released an ITB (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department, with an estimated contract value of $700,000 and a certified Small Local Business Enterprise set-aside. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, effective July 1, 2026. State and local procurement under this code warrants verification against current solicitation records, as the recent activity does not demonstrate sustained demand for amoxicillin as a discrete line item.